Pharmaceutical Technology: Constructing a 570 billion compound AI virtual library and creating a dry-wet closed-loop experimental platform.

PharmaBlock Technology stated on the interactive platform that the company relies on its profound accumulation in the field of molecular building blocks, using over 200,000 molecular building blocks that have been validated for drug properties to provide high-quality data foundation for AI algorithms, thereby improving the rationality and synthetic feasibility of molecular generation from the source. Based on this core advantage, the company has constructed a multi-level drug discovery technology system. They have established a super large capacity virtual compound library based on AI: the company and partner Alipheron jointly created the PharmaBlock Sky Space virtual library, which contains approximately 57 billion novel compounds, based on PharmaBlock's unique building blocks and common reaction designs, combining diversity and drug-like features, and supporting rapid 2D/3D screening through the Hyperspace and Pharos-3D search engines, helping with the discovery of promising compounds. They have also built an integrated dry and wet experimental platform from AI design, synthesis, testing, data feedback.